Clearsite Bio

What Clearsite Bio does

Clearsite Bio (legal entity ClearSite Bio, Inc., a Delaware corporation) sells the Clearsite Active Intelligence System, a distributed data operating system that pharmaceutical organizations deploy inside their own cloud or on-premise environments to make clinical, operational, and multi-omics data instantly queryable across studies, modalities, and teams. The product inverts the traditional pharma data warehouse model by storing data in native form and exposing structure on demand, with security, consent, GxP context, jurisdiction, and audit metadata bound to each data element so that controls travel with the data and are re-evaluated on every read. Underlying components include Apache Accumulo, Apache Spark, Apache ZooKeeper, and Apache Thrift — Accumulo having originated at NSA and the company noting prior Accumulo-class deployments at Google, Meta, Netflix, LinkedIn, and FINRA — alongside higher-level capabilities such as vector embeddings, pre-computed features, model mappings, conditional boundaries for AI agents, and Reactive Consoles for human workflow surfaces.

The platform is positioned against three core pharma R&D use cases: trial efficiency (combining internal performance data with external feasibility data for site, budget, and timeline decisions), protocol optimization (using internal studies and competitive intelligence to improve technical and regulatory probability of success), and reverse translation (connecting specimen, preclinical, and clinical biomarker data across the development continuum). Clearsite frames the bottleneck for AI in pharma as the disconnected data layer rather than the models themselves, citing industry sources indicating that approximately 90% of data in pharma study repositories is never re-examined, per-patient data capture has grown 6x over the past decade, and $40B+ is spent annually on pharma data and analytics, most of it on manual curation.

The business model is enterprise B2B SaaS, sold via direct field sales engagement initiated through [email protected], with revenue inferred to be primarily subscription/recurring software licensing (potentially supplemented by implementation and support services given the platform complexity). Pricing is not publicly disclosed. The company is privately held with no disclosed funding rounds, investors, headcount, named customers, or revenue figures in the input data; leadership pedigree includes former operators from NSA, Merck, Takeda, Koverse (acquired by SAIC), Koneksa, Formation Bio, Foundation Medicine, and the FNIH Biomarkers Consortium.

Name

Clearsite Bio

Legal name

ClearSite Bio, Inc.

Website

https://clearsite.bio

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Clearsite Bio sells the Clearsite Active Intelligence System, a distributed data operating system that pharmaceutical organizations deploy on-premise or in their own cloud to query clinical, operational, and multi-omics data with cell-level security and audit controls bound to every data element.

Ownership category

akta.pro rank

Product category

Pharma Data Infrastructure

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Consent, Preference & Data Rights Management (incl. HIPAA/GDPR support) (HLACAIAG)

akta.pro secondary industry

Data Loss Prevention (DLP) & Sensitive Data Discovery (PHI/PII) (HLACAJAC)

Keywords

• Pharma data infrastructure
• Clinical data management
• Multi-omics data platform
• Distributed data operating system
• Pharmaceutical data analytics

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Enterprise Software Platform: Infrastructure platform sold to pharmaceutical organizations for clinical, operational, and multi-omics data management. Given the enterprise nature, product complexity, and direct sales motion, revenue is inferred to be primarily from software subscriptions and potentially professional services for implementation and support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

The Clearsite Active Intelligence System is a distributed data operating system for clinical, operational, and multi-omics data, making it instantly queryable across studies, modalities, and teams. It ingests data from EDC systems, data lakes, SharePoint, and spreadsheets without requiring custom pipelines or models, and bakes in cell-level security and consent controls that travel with every data element.

Product overview

Clearsite Bio offers a single unified product — the Clearsite Active Intelligence System — which is a distributed data operating system designed specifically for pharmaceutical organizations. The system ingests clinical, operational, and multi-omics data from multiple sources (EDC, data lakes, SharePoint, spreadsheets) and provides a unified queryable layer with built-in governance and security controls that travel with the data. The platform includes components such as Reactive Consoles (human-facing workflow surfaces and viewports into data), Data Shaping & Bindings (pre-computed features, model mappings, vector embeddings), and Conditional Boundaries (policy, consent, and audit bound to data elements).

Differentiator

Problem solved

Functional benefit

Products and services

• Clearsite Active Intelligence System

Quantifiable outcome

• Turns study data questions from projects into queries, eliminating weeks of manual integration work

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Emerging players

• Komodo Health: Komodo Health operates a healthcare and life sciences data platform providing patient-level insights to pharma — comparable to Clearsite in addressing data silos for pharma commercial and R&D use cases.
• eClinical Solutions: eClinical Solutions offers the elluminate clinical data platform with integrated analytics and AI capabilities — a focused, smaller-scale direct competitor to Clearsite's clinical data unification value proposition.
• Atropos Health: Atropos Health delivers real-world evidence generation on top of unified patient data for pharma — adjacent to Clearsite's reverse translation and protocol optimization use cases, with partial overlap on AI-driven clinical data querying.

Direct peers

• Veeva Systems: Veeva's Vault CDMS, CTMS, and clinical data platform are entrenched in pharma R&D data management; Veeva is competing to become the system-of-record that Clearsite aims to integrate above.
• Medidata (Dassault Systèmes): Medidata's Rave EDC and clinical data platform serve most large pharma sponsors and represent the incumbent data capture and management layer Clearsite positions itself to unify across.
• TriNetX: TriNetX operates a clinical research data network connecting EHR and trial data for pharma feasibility and protocol design — a directly comparable use case to Clearsite's trial efficiency and protocol optimization offerings.
• Palantir Technologies: Palantir's Foundry platform and AIP for BioPharma offer AI-ready data unification across clinical, operational, and research datasets — directly competing with Clearsite's distributed data OS for pharma data infrastructure spend.
• Datavant: Datavant focuses on health data connectivity and de-identification, enabling cross-study and cross-source data linkage for life sciences — comparable to Clearsite's cell-level control and cross-study unification approach.

Broad incumbents

• Databricks: Databricks' lakehouse platform, including its healthcare and life sciences solutions, competes for the same data unification layer in pharma — broader than Clearsite but increasingly purpose-built for life sciences use cases.
• IQVIA: IQVIA offers the broadest portfolio in life sciences data, analytics, and clinical operations. As a broad incumbent, it overlaps with Clearsite's positioning around data unification and AI-readiness in pharma R&D.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clearsite-bio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clearsite Bio